Back to top
more

PRA Health Sciences, Inc. (PRAH)

(Delayed Data from NSDQ)

$93.38 USD

93.38
1,010,066

+1.38 (1.50%)

Updated May 3, 2019 04:00 PM ET

After-Market: $93.43 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks News

PRA Health (PRAH) Enters Into Strategic Deal With Deep Lens

PRA Health's (PRAH) deal with Deep Lens can help detect and match oncology patients to suitable clinical trials and best precision therapies.

Urmimala Biswas headshot

Is Another Great Depression Imminent or Is it Just a Myth?

Asian countries have already shown clear signs of major economic recession.

Sriparna Ghosal headshot

3 Remote Patient Monitoring Stocks in Focus Amid Coronavirus

In the wake of the pandemic, the remote patient monitoring space continues to thrive on a number of positive developments.

PRA Health (PRAH) Inks Deal With Leukemia & Lymphoma Society

PRA Health (PRAH) partners with LLS to bring new treatments for children with relapsed acute leukemia.

Why Is PRA Health Sciences (PRAH) Down 9.1% Since Last Earnings Report?

PRA Health Sciences (PRAH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

PRA Health (PRAH) Q2 Earnings and Revenues Beat Estimates

PRA Health's (PRAH) Data Solutions segment puts up a strong performance in Q2.

Analysts Estimate PRA Health Sciences (PRAH) to Report a Decline in Earnings: What to Look Out for

PRA Health Sciences (PRAH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Sriparna Ghosal headshot

3 Digital HealthCare Stocks in the Spotlight Amid Coronavirus

In the face of the pandemic, the digital health management space continues to thrive on a number of positive developments.

PRA Health Boosts Health Harmony COVID-19 Monitoring Program

PRA Health (PRAH) gives a boost to COVID-19 Monitoring program through collaboration with the Microsoft Healthcare Bot service.

Why Is PRA Health Sciences (PRAH) Up 7.3% Since Last Earnings Report?

PRA Health Sciences (PRAH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

PRA Health (PRAH) Q1 Earnings and Revenues Beat Estimates

PRA Health's (PRAH) Clinical Research segment puts up a strong performance in Q1.

PRA Health Sciences (PRAH) Surpasses Q1 Earnings and Revenue Estimates

PRA Health Sciences (PRAH) delivered earnings and revenue surprises of 0.96% and 3.04%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Will PRA Health Sciences (PRAH) Beat Estimates Again in Its Next Earnings Report?

PRA Health Sciences (PRAH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Why PRA Health (PRAH) Might Surprise This Earnings Season

PRA Health (PRAH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Earnings Preview: PRA Health Sciences (PRAH) Q1 Earnings Expected to Decline

PRA Health Sciences (PRAH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Trina Mukherjee headshot

Coronavirus Puts Digital Health in Focus: 3 Stocks to Watch

Let's keep a watch on three stocks that are focusing on digital health to fight against coronavirus.

PRA Health Unit to Offer Free Access to Metys COVID-19 Module

PRA Health's (PRAH) new module is likely to boost Data Solutions segment.

OPKO's BioReference Laboratories Offers COVID-19 Testing (Revised)

OPKO's (OPK) BioReference Laboratories will initially provide testing for facilities at Burlington, Essex, Hudson, Ocean and Union Counties in New Jersey.

PRA Health's New Program to Lend Support to Healthcare System

PRA Health's (PRAH) COVID-19 Monitoring Program will allow individuals to connect with a healthcare professional remotely while maintaining social distancing.

OPKO's BioReference Laboratories Offers COVID-19 Testing

OPKO's (OPK) BioReference Laboratories will initially provide testing for facilities at Burlington, Essex, Hudson, Ocean and Union Counties in New Jersey.

Why Is PRA Health Sciences (PRAH) Down 39.4% Since Last Earnings Report?

PRA Health Sciences (PRAH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

PRA Health (PRAH) Q4 Earnings and Revenues Beat Estimates

Solid Clinical Research revenues drove PRA Health's (PRAH) Q4 results.

Here's Why You Should Retain PRA Health (PRAH) Stock Now

PRA Health (PRAH) is gaining steadily from expansion in international markets, solid 2019 outlook and growing CRO industry. However, escalating direct costs remain a woe.

PRA Health (PRAH) Q3 Earnings and Revenues Beat Estimates

PRA Health (PRAH) raises 2019 EPS view after a solid third-quarter show.

PRA Health Sciences (PRAH) Beats Q3 Earnings and Revenue Estimates

PRA Health Sciences (PRAH) delivered earnings and revenue surprises of 1.54% and 1.01%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?